For many years, clinical protocols for treatment of drug abuse patients and treatment standards in Russian Federation were not grounded on the principles of evidence-based medicine [1] . Recommendations for use of certain drugs were not accompanied by any indication of the level of credibility of the evidence supporting it. The appearance in 2014 of such indications in clinical recommendations can be considered a signifi cant step forward for the science of addiction medicine [2] .
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Despite the fact that traditional psychotherapeutic interventions remain widespread in practice, and treatment of alcohol dependence syndrome showed high effi ciency, there is no convincing evidence for long-term benefi ts as opposed to short-term benefi ts.
The Cochrane Review with data based on 146 scientifi c studies involving 21,404 patients confi rmed the effectiveness of opioid receptor agonists in treatment of opioid dependence. This therapy showed a statistically signifi cant reduction in the use of illegal drugs, HIV transmission and risky sexual behavior, and was signifi cantly more effective compared to the conventional maintenance therapy with opioid receptor antagonists. In countries, where law prohibits prescribing and use of opioid agonists for opioid dependence treatment, the drugs of choice are antagonists.
A meta-analysis of thirteen randomized placebo-controlled trials of oral form of naltrexone (1158 subjects), did not show any advantages of this type of treatment both for management and prevention of relapse compared with placebo [4] . Special studies also showed no inclination to reduce the use of opiates in patients receiving naltrexone [5] . However, studies carried out in Russia, showed the best results for daily intake of naltrexone after detoxifi cation, which increased the duration of remission [6] . It was noted that the effect is associated with higher levels of adherence and family support in the examined population.
An overview based on controlled clinical studies on the use of antipsychotic drugs (neuroleptics) in patients dependent on opioids revealed no evidence of effectiveness of this approach. It was concluded that the use of antipsychotics is justifi ed only in the presence of co-morbid psychiatric problems in patients [7] . In a recent meta-analytic review on the use of atypical antipsychotics for off-label indications (off-label), there was a lack of data to support the effectiveness of their use in substance abuse [8, 9] . The effectiveness of anticonvulsants in the treatment of opioid dependence syndrome has not been proven.
In connection with the above puzzling fact, for Russian standards of treatment (clinical guidelines) the level of credibility of the effectiveness of antipsychotics and antidepressants in treatment of substance abuse is assessed as A or B. This paradox raises the question of the methodology for determining the level of credibility of evidence. It should be noted that Russian recommendations for inclusion of certain drugs and therapies are based on suffi cient consensus of experts rather than on the results of metaanalyses [2] .
CONCLUSIONS:
This fact casts doubt on credibility and validity of scientifi c recommendations. Thus, one may say that Russian addiction medicine is not based on evidence, which is, in our view, erroneous and may impair the quality of care.
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